“We sit in the low 60s in terms of Botox share, and that's a clear leadership position by a large margin in the U.S.,” AbbVie COO Jeff Stewart said on the company’s most recent earnings call on Oct.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback